- Infection control technology company Applied UV Inc AUVI has announced receiving orders over $850 thousand for its Airocide consumer and commercial air purification systems.
- Applied received the order from 3Sixty Biopharmaceuticals, its exclusive distributor within Africa.
- 3Sixty agreed to an upfront binding purchase commitment of a minimum of $3.5 million of Airocide systems over the initial one-year term of the agreement.
- "3Sixty's has made a significant commitment to providing its customers with tested and proven solutions that will help reopen economies across Africa. With its scale, infrastructure, and experience, we believe they are the right partner to make the Airocide system a market leader in Africa," said Q Saeed, CEO, Applied.
- Price action: AUVI shares are trading lower by 2.27% at $10.33 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
